Title Title title T Ti Tit Titl BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 1 0 0 0
Patient-specific alterations patient-specific P Pa Pat Pati BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 10 0 0 0 0 1
cancer patients cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
Authors Authors authors A Au Aut Auth BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 0
Annelien Morlion annelien A An Ann Anne BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 (,),(,,),(,,), 14 10 0 0 0 0 1
Anckaert (1,2), anckaert A An Anc Anck BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 2 (,),(,),(,),(,), 16 10 0 0 0 0 1
Celine Everaert celine C Ce Cel Celi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 3 (),(),(),(,), 13 10 0 0 0 0 0
Mestdagh°* (1,2) mestdagh°* M Me Mes Mest BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 *(,) 4 10 0 0 0 0 0
(1) Department (1) ( (1 (1) (1) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 4 (),,, 5 10 0 0 0 0 0
(2) OncoRNALab, (2) ( (2 (2) (2) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 (),(),, 7 10 0 0 0 0 0
(3) Department (3) ( (3 (3) (3) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 (),,, 5 10 0 0 0 0 0
(4) TOBI (4) ( (4 (4) (4) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 6 (),,-,, 7 10 0 0 0 0 0
(5) Department (5) ( (5 (5) (5) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 (),,, 5 10 0 0 0 0 0
°Both authors °both ° °B °Bo °Bot BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 no 0 10 0 0 0 0 0
*Corresponding author *corresponding * *C *Co *Cor BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 * 1 10 0 0 0 0 0
Author contributions author A Au Aut Auth BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 no 0 10 0 0 0 0 0
Conceptualization: AM, conceptualization: C Co Con Conc BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 8 :,,, 4 10 0 0 0 0 0
Data Curation: data D Da Dat Data BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 : 1 10 0 0 0 0 0
Funding acquisition: funding F Fu Fun Fund BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 :,,, 4 10 0 0 0 0 0
Software: AM, software: S So Sof Soft BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 :, 2 10 0 0 0 0 0
Validation: AM validation: V Va Val Vali BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 : 1 10 0 0 0 0 0
Formal analysis: formal F Fo For Form BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 : 1 10 0 0 0 0 0
Investigation: EV, investigation: I In Inv Inve BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 :,, 3 10 0 0 0 0 0
Methodology: AM, methodology: M Me Met Meth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 :,, 3 10 0 0 0 0 0
Project administration: project P Pr Pro Proj BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 :,, 3 10 0 0 0 0 0
Resources: FO, resources: R Re Res Reso BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 :,,,,, 6 10 0 0 0 0 0
Supervision: JV, supervision: S Su Sup Supe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 :, 2 10 0 0 0 0 0
Visualization: AM visualization: V Vi Vis Visu BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 : 1 10 0 0 0 0 0
Writing -original writing W Wr Wri Writ BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 -:,, 4 10 0 1 0 0 1
Writing -review writing W Wr Wri Writ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 -: 2 10 0 1 0 0 1
Abstract Abstract abstract A Ab Abs Abst BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 0
Circulating nucleic circulating C Ci Cir Circ BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
and disease. and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,- 3 10 0 0 0 0 1
266 cancer 266 2 26 266 266 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 1 -(,; 4 10 0 0 0 0 1
n=58, 3 n=58, n n= n=5 n=58 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 ,).--- 6 10 0 0 0 0 1
transcriptomes compared transcriptomes t tr tra tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 . 1 10 0 0 0 0 0
among patients among a am amo amon BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 ,. 2 10 0 0 0 0 0
Therefore, we therefore, T Th The Ther BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 , 1 10 0 0 0 0 0
reference control reference r re ref refe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -. 2 10 0 0 0 0 0
genes discriminate genes g ge gen gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ,, 2 10 0 0 0 0 0
accuracy (AUC accuracy a ac acc accu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 (.). 4 10 0 0 0 0 0
(2 lymphoma (2 ( (2 (2 (2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 ()()., 6 10 0 0 0 0 0
demonstrate heterogeneity demonstrate d de dem demo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 - 1 10 0 0 0 0 0
that case-specific that t th tha that BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 -. 2 10 0 0 0 0 0
Introduction Introduction introduction I In Int Intr BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 10 0 0 0 0 0
Cancer is cancer C Ca Can Canc BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 , 1 10 0 0 0 0 0
cancer types. cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 10 0 0 0 0 0
well-being and well-being w we wel well BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 -., 3 10 0 0 0 0 0
enabling treatment enabling e en ena enab BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ,, 2 10 0 0 0 0 0
selection or selection s se sel sele BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 . 1 10 0 0 0 0 0
biopsies, liquid biopsies, b bi bio biop BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,- 2 10 0 0 0 0 0
promising tool promising p pr pro prom BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 . 1 10 0 0 0 0 0
To date, to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 , 1 10 0 0 0 0 0
circulating tumor circulating c ci cir circ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 (). 3 10 0 0 0 0 0
on the on o on on on BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 , 1 10 0 0 0 0 0
cancer types cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 -.-() 5 10 0 0 0 0 0
reflecting dynamic reflecting r re ref refl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 , 1 10 0 0 0 0 0
or upon or o or or or BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 ,. 2 10 0 0 0 0 0
cell types cell c ce cel cell BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -, 2 10 0 0 0 0 1
allows monitoring allows a al all allo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --,- 4 10 0 0 0 0 1
and Alzheimer's and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 '. 2 10 0 0 0 0 1
demonstrated for demonstrated d de dem demo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 -. 2 10 0 0 0 0 1
shown potential shown s sh sho show BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 -.. 3 10 0 0 0 0 1
specifically looked specifically s sp spe spec BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 ""() 4 10 0 0 0 0 1
healthy controls healthy h he hea heal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 / 1 10 0 0 0 0 1
indications of indications i in ind indi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 --.. 4 10 0 0 0 0 1
microbe-derived plasma microbe-derived m mi mic micr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 - 1 10 0 0 0 0 0
(colorectum, stomach, (colorectum, ( (c (co (col BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 (,,,,) 6 10 0 0 0 0 0
group-level differences. group-level g gr gro grou BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -.-. 4 10 0 0 0 0 0
for liver for f fo for for BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -, 2 10 0 0 0 0 0
a higher a a a a a BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 0 4 - 1 10 0 0 0 0 0
level differential level l le lev leve BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 .,, 3 10 0 0 0 0 0
major contributors major m ma maj majo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 5 . 1 10 0 0 0 0 0
Here, we here, H He Her Here BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 , 1 10 0 0 0 0 0
different cohorts different d di dif diff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 ().- 4 10 0 0 0 0 0
plasma from plasma p pl pla plas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 - 1 10 0 0 0 0 0
donors to donors d do don dono BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 --. 3 10 0 0 0 0 0
Results revealed results R Re Res Resu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 7 -, 2 10 0 0 0 0 0
questioning the questioning q qu que ques BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 -.,- 4 10 0 0 0 0 0
alterations, reflected alterations, a al alt alte BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,- 2 10 0 0 0 0 0
patient sample patient p pa pat pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 -, 2 10 0 0 0 0 0
distinguish cancer distinguish d di dis dist BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 . 1 10 0 1 0 0 0
Table 1: table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 :.,(),, 7 10 0 1 0 0 0
method and method m me met meth BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 .(*)-, 6 10 0 1 0 0 0
data of data d da dat data BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 (). 3 10 0 1 0 0 0
cohort name cohort c co coh coho BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 no 0 7 0 1 0 0 0
cancer patients cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 10 0 1 0 0 0
(cancer types) (cancer ( (c (ca (can BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 () 2 9 0 1 0 0 0
controls biofluid controls c co con cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 9 0 1 0 0 0
library preparation library l li lib libr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 10 0 1 0 0 0
application application application a ap app appl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 6 0 1 0 0 0
pan-cancer pan-cancer pan-cancer p pa pan pan- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 - 1 10 0 1 0 0 0
cohort cohort cohort c co coh coho BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 no 0 6 0 1 0 0 0
200 (25) 200 2 20 200 200 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 10 () 2 3 0 1 0 0 0
8 8 8 8 8 8 8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 10 no 0 0 0 1 0 0 0
plasma plasma plasma p pl pla plas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 2 0 1 0 0 0
mRNA capture mrna m mR mRN mRNA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 ( 1 10 0 1 0 0 0
Prep with prep P Pr Pre Prep BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 ) 1 8 0 1 0 0 0
discovery discovery discovery d di dis disc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 no 0 10 0 1 0 0 0
three-cancer three-cancer three-cancer t th thr thre BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 - 1 10 0 1 0 0 0
cohort cohort cohort c co coh coho BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 no 0 5 0 1 0 0 0
36 (3) 36 3 36 36 36 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 11 () 2 2 0 1 0 0 0
30* 30* 30* 3 30 30* 30* BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 11 * 1 1 0 1 0 0 0
plasma plasma plasma p pl pla plas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 no 0 2 0 1 0 0 0
mRNA capture mrna m mR mRN mRNA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 ( 1 10 0 1 0 0 0
Prep with prep P Pr Pre Prep BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 ) 1 8 0 1 0 0 0
validation pan-cancer validation v va val vali BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 - 1 8 0 1 0 0 0
analyses & analyses a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 no 0 10 0 1 0 0 0
gene concept gene g ge gen gene BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 1 11 no 0 5 0 1 0 0 0
lymphoma lymphoma lymphoma l ly lym lymp BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 10 0 1 0 0 0
cohort cohort cohort c co coh coho BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 7 0 1 0 0 0
43 (2) 43 4 43 43 43 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 () 2 2 0 1 0 0 1
22 22 22 2 22 22 22 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 no 0 1 0 1 0 0 1
plasma plasma plasma p pl pla plas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 2 0 1 0 0 1
total RNA total t to tot tota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ( 1 10 0 1 0 0 1
Total RNA-Seq total T To Tot Tota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 -- 2 9 0 1 0 0 1
Input Mammalian) input I In Inp Inpu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 ) 1 6 0 1 0 0 1
validation tail validation v va val vali BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 10 0 1 0 0 0
concept concept concept c co con conc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 3 0 1 0 0 0
bladder bladder bladder b bl bla blad BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 5 0 1 0 0 0
cancer cohort cancer c ca can canc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 10 0 1 0 0 0
12 (1) 12 1 12 12 12 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 () 2 2 0 1 0 0 1
12 12 12 1 12 12 12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 no 0 1 0 1 0 0 1
urine urine urine u ur uri urin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 2 0 1 0 0 1
mRNA capture mrna m mR mRN mRNA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ( 1 10 0 1 0 0 1
Exome) Exome) exome) E Ex Exo Exom BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ) 1 2 0 1 0 0 1
validation tail validation v va val vali BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 10 0 1 0 0 0
concept concept concept c co con conc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 3 0 1 0 0 0
Results Results results R Re Res Resu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 1 no 0 10 0 1 0 0 0
A diverse a A A A A BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 1 1 - 1 10 0 1 0 0 1
To characterize to T To To To BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 -, 2 10 0 1 0 0 1
from a from f fr fro from BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 - 1 10 0 0 0 0 0
types and types t ty typ type BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 -(,). 5 10 0 0 0 0 0
sequencing of sequencing s se seq sequ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 -- 2 10 0 0 0 0 0
sample (median sample s sa sam samp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 3 () 2 10 0 0 0 0 0
(Kruskal-Wallis test (kruskal-wallis ( (K (Kr (Kru BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 3 (-.)().([.,.]) 14 10 0 0 0 0 0
of uniquely of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 10 0 0 0 0 0
originated from originated o or ori orig BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (). 3 10 0 0 0 0 0
sample, between sample, s sa sam samp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ,,(,) 5 10 0 0 0 0 0
least 10 least l le lea leas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 10 0 0 0 0 0
gene (Figure gene g ge gen gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 1 5 (). 3 10 0 0 0 0 0
found in found f fo fou foun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ., 2 10 0 0 0 0 0
myeloid leukemia myeloid m my mye myel BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 () 2 10 0 0 0 0 0
solid cancers solid s so sol soli BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 (-.-,.,-- 9 10 0 0 0 0 0
sum q sum s su sum sum BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 .). 3 10 0 0 0 0 0
samples were samples s sa sam samp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 7 , 1 10 0 0 0 0 0
of detected of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 (). 3 10 0 0 0 0 0
using synthetic using u us usi usin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 (). 3 10 0 0 0 0 0
concentrations ranged concentrations c co con conc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 ../. 4 10 0 0 0 0 0
ng/ml. Despite ng/ml. n ng ng/ ng/m BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 /.,- 4 10 0 0 0 0 0
plasma was plasma p pl pla plas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 ., 2 10 0 0 0 0 0
the largest the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 (,./) 5 10 0 0 0 0 0
than the than t th tha than BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 (,./), 6 10 0 0 0 0 0
found between found f fo fou foun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 (-.,., 6 10 0 0 0 0 0
two-sided Wilcoxon two-sided t tw two two- BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 --.)., 6 10 0 0 0 0 0
to the to t to to to BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 10 0 1 0 0 1
at cfDNA at a at at at BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 10 0 1 0 0 1
We then we W We We We BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 10 0 0 0 0 1
transcripts in transcripts t tr tra tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 ., 2 10 0 0 0 0 1
fusion transcripts fusion f fu fus fusi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 . 1 10 0 0 0 0 1
fusion transcripts fusion f fu fus fusi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 .:: 3 10 0 0 0 0 1
fusion transcript fusion f fu fus fusi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 no 0 10 0 0 0 0 1
fusion (7 fusion f fu fus fusi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ().:: 5 10 0 0 0 0 1
fusion was fusion f fu fus fusi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (). 3 10 0 0 0 0 0
plasma samples plasma p pl pla plas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 10 0 0 0 0 0
reported in reported r re rep repo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ()., 4 10 0 0 0 0 0
fusion transcripts fusion f fu fus fusi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 () 2 10 0 0 0 0 0
PML::RARA/RARA::PML fusions pml::rara/rara::pml P PM PML PML: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 ::/::., 7 10 0 0 0 0 0
other fusions other o ot oth othe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 10 0 0 0 0 0
samples. While samples. s sa sam samp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 .:: 3 10 0 0 0 0 0
deeper than deeper d de dee deep BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 , 1 10 0 0 0 0 0
median number median m me med medi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 -. 2 10 0 0 0 0 0
tumor cell-derived tumor t tu tum tumo BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 -. 2 10 0 0 0 0 0
Figure 1: figure F Fi Fig Figu BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 :-,., 5 10 1 1 0 0 0
cancer types cancer c ca can canc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 -. 2 10 1 1 0 0 0
types are types t ty typ type BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 ()(). 5 10 1 1 0 0 0
can be can c ca can can BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 .,,, 4 10 1 1 0 0 0
cancer types cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 .., 3 10 1 1 0 0 0
concentration across concentration c co con conc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 .., 3 10 0 0 0 0 0
show lower show s sh sho show BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 (),,(). 7 10 0 0 0 0 0
to the to t to to to BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 ,,.*(-). 8 10 0 0 0 0 0
More extreme more M Mo Mor More BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 9 ., 2 10 0 0 0 0 0
mRNAs in mrnas m mR mRN mRNA BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 10 -().: 5 10 0 0 0 0 0
samples; red samples; s sa sam samp BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ;:;:-., 7 10 0 1 0 0 1
Principal component principal P Pr Pri Prin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 () 2 10 0 1 0 0 1
or prostate or o or or or BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 (),..: 6 10 0 0 0 0 1
component. component. component. c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 . 1 10 0 0 0 0 0
Differential mRNA differential D Di Dif Diff BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 ' 1 10 0 0 0 0 1
Principal component principal P Pr Pri Prin BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 10 0 0 0 0 1
samples for samples s sa sam samp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 2 (). 3 10 0 0 0 0 1
between samples between b be bet betw BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 . 1 10 0 0 0 0 1
patient samples patient p pa pat pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 no 0 10 0 0 0 0 0
(Figure 1e (figure ( (F (Fi (Fig BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 (,), 4 10 0 0 0 0 0
patients differ patients p pa pat pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 . 1 10 0 0 0 0 0
Differentially abundant differentially D Di Dif Diff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 -, 2 10 0 0 0 0 0
numbers varying numbers n nu num numb BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 4 () 2 10 0 0 0 0 0
2727 (median 2727 2 27 272 2727 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 5 ()(). 5 10 0 0 0 0 0
Most differentially most M Mo Mos Most BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 (), 3 10 0 0 0 0 0
cancer (UCEC) cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ()(),. 6 10 0 0 0 0 0
(HNSC), rectal (hnsc), ( (H (HN (HNS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 (),()() 7 10 0 0 0 0 0
abundant mRNAs abundant a ab abu abun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 (,,). 5 10 0 0 0 0 0
In total, in I In In In BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 7 ,- 2 10 0 0 0 0 0
comparisons (b) comparisons c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 ().. 4 10 0 0 0 0 0
abundant mRNAs abundant a ab abu abun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 .. 2 10 0 0 0 0 0
differential mRNA differential d di dif diff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 no 0 10 0 0 0 0 0
variability in variability v va var vari BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 (,). 4 10 0 0 0 0 0
4442 mRNAs 4442 4 44 444 4442 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 9 ()(), 5 10 0 0 0 0 0
(3680 mRNAs) (3680 ( (3 (36 (368 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 10 (). 3 10 0 0 0 0 0
plasma of plasma p pl pla plas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 , 1 10 0 0 0 0 0
in 23 in i in in in BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 11 -(). 4 10 0 0 0 0 0
in cancer in i in in in BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 no 0 10 1 1 0 0 1
response pathways response r re res resp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 (). 3 10 1 1 0 0 1
Figure 2: figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 :., 3 10 1 1 0 0 0
from cancer from f fr fro from BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 . 1 10 1 1 0 0 0
mRNAs (q mrnas m mR mRN mRNA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 (.)., 5 10 1 1 0 0 0
in anaplastic in i in in in BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 9 ()(). 5 10 1 1 0 0 0
line at line l li lin line BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .-,.(): 7 10 0 1 0 0 1
compared to compared c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (.);(): 7 10 0 1 0 0 1
compared to compared c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 (.-). 5 10 0 0 0 0 1
differentially abundant differentially d di dif diff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ()()( 5 10 0 0 0 0 1
counts+1) followed counts+1) c co cou coun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 )-. 3 10 0 0 0 0 1
correlation. d, correlation. c co cor corr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 .,(). 5 10 0 0 0 0 1
Enrichment of enrichment E En Enr Enri BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 ' 1 10 0 0 0 0 1
To explore to T To To To BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 , 1 10 0 0 0 0 1
in cancer in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 3 ,, 2 10 0 0 0 0 0
Encyclopedia of encyclopedia E En Enc Ency BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 (),- 4 10 0 0 0 0 0
(Figure 3a, (figure ( (F (Fi (Fig BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 (,). 4 10 0 0 0 0 0
immune-related signals immune-related i im imm immu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 -(,, 4 10 0 0 0 0 0
and neutrophils) and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ),. 3 10 0 0 0 0 0
cancer types. cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 .''(. 5 10 0 0 0 0 0
out of out o ou out out BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ).. 3 10 0 0 0 0 0
cfRNA profiles cfrna c cf cfR cfRN BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 -. 2 10 0 0 0 0 0
q<0.05 in q<0.05 q q< q<0 q<0. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .''''. 6 10 0 0 0 0 0
Conversely, 'extracellular conversely, C Co Con Conv BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 ,'''' 5 10 0 0 0 0 0
positively enriched positively p po pos posi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 ,. 2 10 0 0 0 0 0
positively enriched positively p po pos posi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 '-','', 7 10 0 0 0 0 0
'adipose tissue', 'adipose ' 'a 'ad 'adi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 '','',''. 9 10 0 0 0 0 0
Cancer type-specific cancer C Ca Can Canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 - 1 10 0 0 0 0 0
for liver for f fo for for BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 .'','','' 9 10 0 0 0 0 0
all positively all a al all all BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 '(.,) 5 10 0 0 0 0 0
from any from f fr fro from BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 .'' 3 10 0 0 0 0 0
in lung in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 9 (.;.), 6 10 0 0 0 0 0
but this but b bu but but BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 (,,,). 6 10 0 0 0 0 0
We then we W We We We BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 no 0 10 0 0 0 0 0
contributing to contributing c co con cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 ()., 4 10 0 0 0 0 0
erythrocytes/erythrocyte progenitors, erythrocytes/erythrocyte e er ery eryt BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 /,,,-- 6 10 0 0 0 0 0
5 of 5 5 5 5 5 BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 11 no 0 10 0 0 0 0 0
with solid with w wi wit with BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ()., 4 10 0 1 0 0 1
the most the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 10 0 1 0 0 1
patients showed patients p pa pat pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 .- 2 10 0 0 0 0 1
stem cells, stem s st ste stem BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ,,- 3 10 0 0 0 0 1
present in present p pr pre pres BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 , 1 10 0 0 0 0 1
patients 11 patients p pa pat pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 .,, 3 10 0 0 0 0 1
second most second s se sec seco BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 (.), 4 10 0 0 0 0 1
signal in signal s si sig sign BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 (.)()., 7 10 0 0 0 0 1
fraction in fraction f fr fra frac BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 (- 2 10 0 0 0 0 0
Wilcoxon rank wilcoxon W Wi Wil Wilc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 .-,.). 6 10 0 0 0 0 0
62.3% in 62.3% 6 62 62. 62.3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 ., 2 10 0 0 0 0 0
leukemia patients leukemia l le leu leuk BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 . 1 10 0 0 0 0 0
In plasma in I In In In BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 7 , 1 10 0 0 0 0 0
compared to compared c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 (,--.-, 7 10 0 0 0 0 0
size=0.163), which size=0.163), s si siz size BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 .), 3 10 0 0 0 0 0
occurrence of occurrence o oc occ occu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 ,., 3 10 0 0 0 0 0
erythrocyte/erythroid progenitor erythrocyte/erythroid e er ery eryt BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 9 /,,-, 5 10 0 0 0 0 0
lower in lower l lo low lowe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 '(--.- 6 10 0 0 0 0 0
2 (effect 2 2 2 2 2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 10 (.),.-(.),.-(.),.- 18 10 0 0 0 0 0
(effect size=0.252), (effect ( (e (ef (eff BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 (.),). 6 10 0 0 0 0 0
Figure 3: figure F Fi Fig Figu BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 :--. 4 10 1 1 0 0 0
a, Gene a, a a, a, a, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,. 2 10 1 1 0 0 0
enriched in enriched e en enr enri BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 .. 2 10 1 1 0 0 0
enrichment scores enrichment e en enr enri BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 ().,-, 6 10 1 1 0 0 0
with q with w wi wit with BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ..., 4 10 1 1 0 0 0
fraction of fraction f fr fra frac BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 .:. 3 10 0 0 0 0 0
The five the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 . 1 10 0 0 0 0 0
Independent validation independent I In Ind Inde BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 10 0 0 0 0 0
To validate to T To To To BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 ,(-) 4 10 0 0 0 0 0
samples which, samples s sa sam samp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 8 ,, 2 10 0 0 0 0 0
cancer-free control cancer-free c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 - 1 10 0 0 0 0 0
types: prostate types: t ty typ type BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 :(,),(,),(,). 13 10 0 0 0 0 0
paired-end reads paired-end p pa pai pair BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 -() 3 10 0 0 0 0 0
sequencing depth sequencing s se seq sequ BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (-.)(). 7 10 0 1 0 0 1
with the with w wi wit with BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -,, 3 10 0 1 0 0 1
(Supplemental Figure (supplemental ( (S (Su (Sup BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (),- 4 10 0 0 0 0 1
cancer cohort. cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 .../( 5 10 0 0 0 0 1
8c). 8c). 8c). 8 8c 8c) 8c). BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 ). 2 10 0 0 0 0 0
Most cancer most M Mo Mos Most BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 1 , 1 10 0 0 0 0 1
especially for especially e es esp espe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 (). 3 10 0 0 0 0 1
analyses between analyses a an ana anal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 , 1 10 0 0 0 0 1
abundant mRNAs abundant a ab abu abun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 (,),( 5 10 0 0 0 0 0
higher abundant, higher h hi hig high BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 ,)(). 5 10 0 0 0 0 0
abundant mRNAs abundant a ab abu abun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 (,) 3 10 0 0 0 0 0
though this though t th tho thou BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 - 1 10 0 0 0 0 0
cohort. Hierarchical cohort. c co coh coho BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 .- 2 10 0 0 0 0 0
cohort mostly cohort c co coh coho BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 no 0 10 0 0 0 0 0
abundance within abundance a ab abu abun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (). 3 10 0 0 0 0 0
189 and 189 1 18 189 189 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 5 ,, 2 10 0 0 0 0 0
from all from f fr fro from BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (). 3 10 0 0 0 0 0
included all included i in inc incl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 - 1 10 0 0 0 0 0
cancer cohort. cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 .,, 3 10 0 0 0 0 0
mRNAs between mrnas m mR mRN mRNA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 -- 2 10 0 0 0 0 0
types (Fisher's types t ty typ type BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 (':.-(.), 9 10 0 0 0 0 0
p=1.1E-155 (odds p=1.1e-155 p p= p=1 p=1. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 .-(.),.-(.);: 13 10 0 0 0 0 0
OV p=4.0E-4 ov O OV OV OV BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 .-(.),.-(.),.-( 15 10 0 0 0 0 0
ratio=3.3); Jaccard ratio=3.3); r ra rat rati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 .);[.-.])(). 12 10 0 0 0 0 0
38%, 49%, 38%, 3 38 38% 38%, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 ,,,,- 5 10 0 0 0 0 0
cancer cohort cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 -., 3 10 0 0 0 0 0
abundance showed abundance a ab abu abun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 10 0 0 0 0 0
abundance. abundance. abundance. a ab abu abun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 . 1 10 0 0 0 0 0
In line in I In In In BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 10 -, 2 10 0 0 0 0 0
reflecting tumor reflecting r re ref refl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 11 ,- 2 10 0 0 0 0 0
cohort. However, cohort. c co coh coho BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 ., 2 10 0 0 0 0 0
pan-cancer cohort pan-cancer p pa pan pan- BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 --, 3 10 0 1 0 0 1
(Figure 4d, (figure ( (F (Fi (Fig BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (,). 4 10 0 1 0 0 1
Cell type cell C Ce Cel Cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 1 ,/, 3 10 0 0 0 0 1
monocytes and monocytes m mo mon mono BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 --(, 4 10 0 0 0 0 1
Supplemental Table supplemental S Su Sup Supp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 ),. 3 10 0 0 0 0 1
The higher the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 - 1 10 0 0 0 0 1
cancer cohort cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 (--.-, 6 10 0 0 0 0 1
0.679), especially 0.679), 0 0. 0.6 0.67 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 .),()., 7 10 0 0 0 0 1
erythrocyte/erythroid progenitor erythrocyte/erythroid e er ery eryt BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 /,- 3 10 0 0 0 0 0
fraction in fraction f fr fra frac BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 (--.- 5 10 0 0 0 0 0
(effect size=0.556), (effect ( (e (ef (eff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 (.),.-(.),.-(.),.-( 19 10 0 0 0 0 0
size=0.261), respectively). size=0.261), s si siz size BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 .),). 5 10 0 0 0 0 0
Taken together, taken T Ta Tak Take BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 ,- 2 10 0 0 0 0 0
cancer and cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 -, 2 10 0 0 0 0 0
and cell and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 11 no 0 10 0 0 0 0 0
cancer patients. cancer c ca can canc BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 11 . 1 10 0 0 0 0 0
Figure 4: figure F Fi Fig Figu BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 :--,, 5 10 1 1 0 0 0
overlap in overlap o ov ove over BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 ., 2 10 1 1 0 0 0
shows distinct shows s sh sho show BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ()., 4 10 1 1 0 0 0
0verlap between 0verlap 0 0v 0ve 0ver BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 -. 2 10 1 1 0 0 0
proportional to proportional p pr pro prop BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 ., 2 10 1 1 0 0 0
control for control c co con cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 --.':.-,., 10 10 0 0 0 0 0
index=8.3% for index=8.3% i in ind inde BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 .();.-,., 9 10 0 0 0 0 0
index=14.3% for index=14.3% i in ind inde BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 .().., 6 10 0 0 0 0 0
enrichment analysis enrichment e en enr enri BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 .. 2 10 0 0 0 0 0
with q with w wi wit with BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 .()., 5 10 0 0 0 0 0
abundant cell abundant a ab abu abun BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .: 2 10 0 1 0 0 1
types. Differential types. t ty typ type BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .:..:;:;: 9 10 0 1 0 0 1
uterine cancer. uterine u ut ute uter BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 . 1 10 0 0 0 0 0
cfRNA tail cfrna c cf cfR cfRN BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 1 no 0 10 0 0 0 0 1
Apart from apart A Ap Apa Apar BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 1 , 1 10 0 0 0 0 1
of origin of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 no 0 10 0 0 0 0 1
plasma. Moreover, plasma. p pl pla plas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 ., 2 10 0 0 0 0 1
showed lower showed s sh sho show BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 no 0 10 0 0 0 0 0
in cancer in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 2 . 1 10 0 0 0 0 0
immune response immune i im imm immu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 ., 2 10 0 0 0 0 0
hypothesized that hypothesized h hy hyp hypo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 (), 3 10 0 0 0 0 0
that classic that t th tha that BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 10 0 0 0 0 0
reveal such reveal r re rev reve BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 -. 2 10 0 0 0 0 0
individual cancer individual i in ind indi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 -. 2 10 0 0 0 0 0
To capture to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 4 , 1 10 0 0 0 0 0
mRNA abundance mrna m mR mRN mRNA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 no 0 10 0 0 0 0 0
entire control entire e en ent enti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ,.,- 4 10 0 0 0 0 0
for each for f fo for for BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 no 0 10 0 0 0 0 0
distribution in distribution d di dis dist BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 .- 2 10 0 0 0 0 0
defined as defined d de def defi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 "", 3 10 0 0 0 0 0
control z-score control c co con cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 -(). 4 10 0 0 0 0 0
We searched we W We We We BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 7 -( 2 10 0 0 0 0 0
could take could c co cou coul BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 ), 2 10 0 0 0 0 0
other control other o ot oth othe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 (). 3 10 0 0 0 0 0
unique tail unique u un uni uniq BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 no 0 10 0 0 0 0 0
plasma samples plasma p pl pla plas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 (-., 4 10 0 0 0 0 0
size=0.222, Figure size=0.222, s si siz size BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 9 .,). 4 10 0 0 0 0 0
cancer samples cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 ().,. 5 10 0 0 0 0 0
that were that t th tha that BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 ,(.. 4 10 0 0 0 0 0
negative z-score) negative n ne neg nega BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 11 -) 2 10 0 0 0 0 0
differential abundance differential d di dif diff BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 11 ,. 2 10 0 0 0 0 0
Notably, the notably, N No Not Nota BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ,; 2 10 0 1 0 0 1
of the of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 10 0 1 0 0 1
genes were genes g ge gen gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (). 3 10 0 0 0 0 1
To determine to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 1 , 1 10 0 0 0 0 1
prior to prior p pr pri prio BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 ., 2 10 0 0 0 0 1
observe a observe o ob obs obse BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 no 0 10 0 0 0 0 1
samples and samples s sa sam samp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 2 (-.), 5 10 0 0 0 0 1
increased number increased i in inc incr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 . 1 10 0 0 0 0 1
Tail genes tail T Ta Tai Tail BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 no 0 10 0 0 0 0 0
another cancer another a an ano anot BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 ('.-,:[.-.]), 13 10 0 0 0 0 0
similarity (Jaccard similarity s si sim simi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 (:[.-.])(). 11 10 0 0 0 0 0
showed significant showed s sh sho show BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 ( 1 10 0 0 0 0 0
p: [5.9E-15 p: p p: p: p: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 :[.--.-],:[.-.])(:[.-.]). 25 10 0 0 0 0 0
63% of 63% 6 63 63% 63% BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 . 1 10 0 0 0 0 0
Seven Cancer seven S Se Sev Seve BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 () 2 10 0 0 0 0 0
sample, which sample, s sa sam samp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ,('., 5 10 0 0 0 0 0
ratio=3.13). While ratio=3.13). r ra rat rati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 .)., 4 10 0 0 0 0 0
was found was w wa was was BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 (,,). 5 10 0 0 0 0 0
Overrepresentation analyses overrepresentation O Ov Ove Over BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 7 (,) 3 10 0 0 0 0 0
that tail that t th tha that BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 () 2 10 0 0 0 0 0
different processes different d di dif diff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 ,, 2 10 0 0 0 0 0
and extracellular and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 .(- 3 10 0 0 0 0 0
3) were 3) 3 3) 3) 3) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 ). 2 10 0 0 0 0 0
the cancer the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 , 1 10 0 0 0 0 0
in the in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 9 () 2 10 0 0 0 0 0
types compared types t ty typ type BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 . 1 10 0 0 0 0 0
Given the given G Gi Giv Give BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 9 , 1 10 0 0 0 0 0
binary (cancer/control) binary b bi bin bina BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 (/). 4 10 0 0 0 0 0
first selected first f fi fir firs BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 ,, 2 10 0 0 0 0 0
associated to associated a as ass asso BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 --( 3 10 0 0 0 0 0
Methods for methods M Me Met Meth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 )., 3 10 0 0 0 0 0
in number in i in in in BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 11 (-- 3 10 0 0 0 0 0
sum p=3.1E-11, sum s su sum sum BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .-,.). 6 10 0 1 0 0 1
in control in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 0 no 0 10 0 1 0 0 1
compared to compared c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 (). 3 10 0 0 0 0 1
strategy to strategy s st str stra BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 10 0 0 0 0 1
fewer or fewer f fe few fewe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 :(:) 4 10 0 0 0 0 1
instead of instead i in ins inst BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 . 1 10 0 0 0 0 0
When selecting when W Wh Whe When BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 2 , 1 10 0 0 0 0 1
143 biomarker 143 1 14 143 143 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 3 ,,. 3 10 0 0 0 0 1
biomarker tail biomarker b bi bio biom BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 no 0 10 0 0 0 0 0
more significant more m mo mor more BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 (--:.- 6 10 0 0 0 0 0
and effect and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 .;.-.;.- 8 10 0 0 0 0 0
size=0.912) (Figure size=0.912) s si siz size BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .)().- 6 10 0 0 0 0 0
significant overlap significant s si sig sign BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ('.-,:[.-.]) 12 10 0 0 0 0 0
(Jaccard index: (jaccard ( (J (Ja (Jac BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 (:[.-.])(). 11 10 0 0 0 0 0
We then we W We We We BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 10 0 0 0 0 0
of biomarker of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 .---, 5 10 0 0 0 0 0
obtained perfect obtained o ob obt obta BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 10 0 0 0 0 0
(AUC=1.000, based (auc=1.000, ( (A (AU (AUC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 (.,,.), 7 10 0 0 0 0 0
performance for performance p pe per perf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 (., 3 10 0 0 0 0 0
genes) (Figure genes) g ge gen gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 )(). 4 10 0 0 0 0 0
samples (AUC=0.980, samples s sa sam samp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 10 (.,). 5 10 0 0 0 0 0
Together, these together, T To Tog Toge BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 , 1 10 0 0 0 0 0
controls based controls c co con cont BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 . 1 10 0 0 0 0 0
Figure 5: figure F Fi Fig Figu BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 :()., 5 10 1 1 0 0 0
Tail gene tail T Ta Tai Tail BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 . 1 10 1 1 0 0 0
standard deviations standard s st sta stan BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 . 1 10 1 1 0 0 0
of tail of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 /., 3 10 1 1 0 0 0
group, with group, g gr gro grou BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ,.-.,..- 8 10 1 1 0 0 0
sided Wilcoxon sided s si sid side BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 --.,- 5 10 0 0 0 0 0
distribution of distribution d di dis dist BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 , 1 10 0 0 0 0 0
the samples the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 .,---, 6 10 0 0 0 0 0
respectively. Genes respectively. r re res resp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 .()., 5 10 0 0 0 0 0
fraction of fraction f fr fra frac BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 .., 3 10 0 0 0 0 0
genes detected genes g ge gen gene BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ., 2 10 0 1 0 0 1
(CONTROL) versus (control) ( (C (CO (CON BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 (). 3 10 0 1 0 0 1
comparison: 108 comparison: c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 :(),,, 6 10 0 0 0 0 1
for UCEC for f fo for for BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ..--- 5 10 0 0 0 0 1
indicated in indicated i in ind indi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 .,---/ 6 10 0 0 0 0 1
based on based b ba bas base BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 (), 3 10 0 0 0 0 1
samples (PRAD), samples s sa sam samp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 2 (),(),() 8 10 0 0 0 0 1
gene sets. gene g ge gen gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 5 2 .,-.(),, 8 10 0 0 0 0 1
and upper and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 ()., 4 10 0 0 0 0 1
respectively, within respectively, r re res resp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 ,.*(-). 7 10 0 0 0 0 1
as individual as a as as as BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 .-(), 5 10 0 0 0 0 0
ovarian cancer ovarian o ov ova ovar BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 (),(),(). 9 10 0 0 0 0 0
To independently to T To To To BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 4 , 1 10 0 0 0 0 0
we generated we w we we we BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (), 3 10 0 0 0 0 0
from 22 from f fr fro from BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -, 2 10 0 0 0 0 0
large B-cell large l la lar larg BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 5 -()-() 6 10 0 0 0 0 0
patients. We patients. p pa pat pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ., 2 10 0 0 0 0 0
compared to compared c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 (-.-,.,). 9 10 0 0 0 0 0
All control all A Al All All BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 . 1 10 0 0 0 0 0
44.2% of 44.2% 4 44 44. 44.2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 7 ., 2 10 0 0 0 0 0
respectively (Supplemental respectively r re res resp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 ().() 5 10 0 0 0 0 0
tail gene tail t ta tai tail BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 , 1 10 0 0 0 0 0
and control and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 (-.). 5 10 0 0 0 0 0
Among the among A Am Amo Amon BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 ,-- 3 10 0 0 0 0 0
out Fisher's out o ou out out BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 '. 2 10 0 0 0 0 0
was significantly was w wa was was BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 (- 2 10 0 0 0 0 0
Wilcoxon rank-sum: wilcoxon W Wi Wil Wilc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 -:.-,.;.-, 10 10 0 0 0 0 0
size=0.811, Figure size=0.811, s si siz size BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 .,).(/) 7 10 0 0 0 0 0
leave-one-out cross-validation leave-one-out l le lea leav BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 ---.., 6 10 0 0 0 0 0
respectively (Figure respectively r re res resp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 (). 3 10 0 0 0 0 0
any lymphoma any a an any any BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 11 .,- 3 10 0 0 0 0 0
displayed an displayed d di dis disp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 11 ().(.. 6 10 0 0 0 0 0
DLBCL or dlbcl D DL DLB DLBC BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 11 ) 1 10 0 0 0 0 0
genes (p=1.8E-4 genes g ge gen gene BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (.-.-,) 7 10 0 1 0 0 1
including diagnosis including i in inc incl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 10 0 1 0 0 1
To test to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 - 1 10 0 0 0 0 1
applicable to applicable a ap app appl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 ,( 2 10 0 0 0 0 1
cohort) 14 cohort) c co coh coho BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 ).() 4 10 0 0 0 0 1
cancer-free control cancer-free c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 -. 2 10 0 0 0 0 1
tail gene. tail t ta tai tail BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 . 1 10 0 0 0 0 1
controls (two-sided controls c co con cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 (--.-.,) 8 10 0 0 0 0 0
of biomarker of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 no 0 10 0 0 0 0 0
group. In group. g gr gro grou BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ., 2 10 0 0 0 0 0
did not did d di did did BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 no 0 10 0 0 0 0 0
cancer samples cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 .-- 3 10 0 0 0 0 0
out cross-validation out o ou out out BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 -.(). 5 10 0 0 0 0 0
Taken together, taken T Ta Tak Take BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 9 , 1 10 0 0 0 0 0
cfRNA enables cfrna c cf cfR cfRN BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 10 no 0 10 0 0 0 0 0
concept may concept c co con conc BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 11 . 1 10 0 0 0 0 0
Figure 6: figure F Fi Fig Figu BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 : 1 10 1 1 0 0 0
independent blood independent i in ind inde BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .-,:, 5 10 1 1 0 0 0
large B-cell large l la lar larg BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 1 -(),-()., 9 10 1 1 0 0 0
of number of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 . 1 10 1 1 0 0 0
tail genes tail t ta tai tail BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 :,. 3 10 1 1 0 0 0
represent individual represent r re rep repr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 .--.,-- 7 10 0 0 0 0 0
cross-validated classifier cross-validated c cr cro cros BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 -/ 2 10 0 0 0 0 0
control and control c co con cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ,., 3 10 0 0 0 0 0
tail genes tail t ta tai tail BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 .-,: 4 10 0 0 0 0 0
(CONTROL) and (control) ( (C (CO (CON BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 7 ()()., 6 10 0 0 0 0 0
cancer samples. cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 ..--., 6 10 0 0 0 0 0
ROC curve roc R RO ROC ROC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 9 ---/ 4 10 0 0 0 0 0
of biomarker of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 .:,,,.*; 8 10 0 0 0 0 0
more extreme more m mo mor more BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 11 . 1 10 0 0 0 0 0
Discussion Discussion discussion D Di Dis Disc BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 10 0 1 0 0 0
In this in I In In In BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 0 ,- 2 10 0 0 0 0 1
investigated if investigated i in inv inve BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 10 0 0 0 0 1
pan-cancer discovery pan-cancer p pa pan pan- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 10 0 0 0 0 1
direct evidence direct d di dir dire BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 -:: 3 10 0 0 0 0 1
transcripts. Also, transcripts. t tr tra tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 ., 2 10 0 0 0 0 1
progenitor cells, progenitor p pr pro prog BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 ,---. 5 10 0 0 0 0 1
For solid for F Fo For For BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 2 , 1 10 0 0 0 0 1
versus control versus v ve ver vers BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 ,- 2 10 0 0 0 0 0
liver cancer liver l li liv live BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 -. 2 10 0 0 0 0 0
contributor to contributor c co con cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 no 0 10 0 0 0 0 0
facilitate mRNA facilitate f fa fac faci BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 . 1 10 0 0 0 0 0
from the from f fr fro from BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ., 2 10 0 0 0 0 0
enrichment of enrichment e en enr enri BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 -, 2 10 0 0 0 0 0
plasma from plasma p pl pla plas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 ,. 2 10 0 0 0 0 0
Considering the considering C Co Con Cons BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 5 , 1 10 0 0 0 0 0
be better be b be be be BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -., 3 10 0 0 0 0 0
could not could c co cou coul BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -- 2 10 0 0 0 0 0
transcripts in transcripts t tr tra tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 , 1 10 0 0 0 0 0
seminal plasma seminal s se sem semi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 . 1 10 0 0 0 0 0
We did we W We We We BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 7 '- 2 10 0 0 0 0 0
cancer cohort, cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 ,. 2 10 0 0 0 0 0
immune-related mRNAs immune-related i im imm immu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 - 1 10 0 0 0 0 0
patients. It patients. p pa pat pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 . 1 10 0 0 0 0 0
system, and system, s sy sys syst BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 , 1 10 0 0 0 0 0
activity profiles activity a ac act acti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 . 1 10 0 0 0 0 0
immune-related mRNA immune-related i im imm immu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 -,.() 5 10 0 0 0 0 0
cell-related mRNA cell-related c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 - 1 10 0 0 0 0 0
from several from f fr fro from BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 ,- 2 10 0 0 0 0 0
lower abundant lower l lo low lowe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 11 ., 2 10 0 0 0 0 0
neutrophil cell-free neutrophil n ne neu neut BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 11 - 1 10 0 0 0 0 0
tumor sites. tumor t tu tum tumo BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .,/ 3 10 0 1 0 0 1
anemia, a anemia, a an ane anem BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,. 2 10 0 1 0 0 1
positively enriched positively p po pos posi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 10 0 0 0 0 1
progression and progression p pr pro prog BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 ,-- 3 10 0 0 0 0 1
blood vessel blood b bl blo bloo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 . 1 10 0 0 0 0 1
A limitation a A A A A BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 7 1 - 1 10 0 0 0 0 1
and sex-matched. and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 -.,, 4 10 0 0 0 0 1
patients were patients p pa pat pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 . 1 10 0 0 0 0 1
cohort with cohort c co coh coho BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 - 1 10 0 0 0 0 0
these cancer these t th the thes BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 ., 2 10 0 0 0 0 0
group, this group, g gr gro grou BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 ,-(.. 5 10 0 0 0 0 0
prostate, testicular, prostate, p pr pro pros BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 ,,,,)., 7 10 0 0 0 0 0
at most at a at at at BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 - 1 10 0 0 0 0 0
the pan-cancer the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 -, 2 10 0 0 0 0 0
of the of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 -. 2 10 0 0 0 0 0
size per size s si siz size BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 , 1 10 0 0 0 0 0
true differences. true t tr tru true BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 6 . 1 10 0 0 0 0 0
The variable the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 , 1 10 0 0 0 0 0
abundant mRNAs abundant a ab abu abun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 10 0 0 0 0 0
that can that t th tha that BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 . 1 10 0 0 0 0 0
requirement by requirement r re req requ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 no 0 10 0 0 0 0 0
deviates from deviates d de dev devi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 . 1 10 0 0 0 0 0
biomarker gene biomarker b bi bio biom BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 -, 2 10 0 0 0 0 0
differential abundance differential d di dif diff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 ., 2 10 0 0 0 0 0
dark channel dark d da dar dark BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 () 2 10 0 0 0 0 0
therefore cannot therefore t th the ther BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 no 0 10 0 0 0 0 0
healthy plasma healthy h he hea heal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 ., 2 10 0 0 0 0 0
lung and lung l lu lun lung BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 . 1 10 0 0 0 0 0
control samples control c co con cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 ,""(.. 6 10 0 0 0 0 0
transcripts in transcripts t tr tra tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 )-. 3 10 0 0 0 0 0
Tail gene tail T Ta Tai Tail BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 11 . 1 10 0 0 0 0 0
that it that t th tha that BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 11 , 1 10 0 0 0 0 0
believe it believe b be bel beli BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 10 0 0 0 0 1
Nevertheless, it nevertheless, N Ne Nev Neve BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ,-. 3 10 0 0 0 0 1
control group control c co con cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,- 2 10 0 0 0 0 1
collection to collection c co col coll BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 --. 3 10 0 0 0 0 1
approach should approach a ap app appr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 no 0 10 0 0 0 0 1
distributions between distributions d di dis dist BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 -- 2 10 0 0 0 0 1
cancer or cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 ., 2 10 0 0 0 0 1
variables (blood variables v va var vari BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 (,, 3 10 0 0 0 0 1
extraction kit) extraction e ex ext extr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 ). 2 10 0 0 0 0 0
Deviations in deviations D De Dev Devi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 3 , 1 10 0 0 0 0 0
blood plasma. blood b bl blo bloo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ., 2 10 0 0 0 0 0
identify bladder identify i id ide iden BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 . 1 10 0 0 0 0 0
genes, although genes, g ge gen gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 ,(). 4 10 0 0 0 0 0
examine the examine e ex exa exam BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 -., 3 10 0 0 0 0 0
while we while w wh whi whil BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 10 0 0 0 0 0
numerous in numerous n nu num nume BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ,- 2 10 0 0 0 0 0
across various across a ac acr acro BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 - 1 10 0 0 0 0 0
screening or screening s sc scr scre BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 . 1 10 0 0 0 0 0
Methods Methods methods M Me Met Meth BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 no 0 10 0 1 0 0 0
Sample cohorts sample S Sa Sam Samp BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 7 no 0 10 0 1 0 0 0
The study the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 ,(. 3 10 0 1 0 0 0
B670201734362) and b670201734362) B B6 B67 B670 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 8 ). 2 10 0 1 0 0 0
Pan-cancer plasma pan-cancer P Pa Pan Pan- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 8 -- 2 10 0 1 0 0 0
Blood plasma blood B Bl Blo Bloo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 8 (,) 3 10 0 1 0 0 0
informed consent informed i in inf info BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 .- 2 10 0 1 0 0 0
types and types t ty typ type BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 -., 3 10 0 1 0 0 0
donors. The donors. d do don dono BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 .-(),(), 8 10 0 1 0 0 0
and endometrial and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 (),. 4 10 0 0 0 0 0
included plasma included i in inc incl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 11 - 1 10 0 0 0 0 0
22 additional 22 2 22 22 22 BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 11 .-, 3 10 0 0 0 0 0
control samples control c co con cont BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ., 2 10 0 0 0 0 1
control samples control c co con cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -. 2 10 0 0 0 0 1
All cancer all A Al All All BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ()( 3 10 0 0 0 0 1
4), except 4), 4 4) 4), 4), BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 1 ),(). 5 10 0 0 0 0 1
exceptions: 4 exceptions: e ex exc exce BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 :(-) 4 10 0 1 0 0 1
therapy, one therapy, t th the ther BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 ,, 2 10 0 1 0 0 1
melanoma patient melanoma m me mel mela BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 . 1 10 0 1 0 0 1
information can information i in inf info BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 . 1 10 0 1 0 0 1
Lymphoma cohort lymphoma L Ly Lym Lymp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 no 0 10 0 1 0 0 0
The lymphoma the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 3 : 1 10 0 1 0 0 0
patients, 13 patients, p pa pat pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 ,,-. 4 10 0 1 0 0 0
collected following collected c co col coll BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 , 1 10 0 1 0 0 0
(B670201733701), and (b670201733701), ( (B (B6 (B67 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 4 (),,. 5 10 0 1 0 0 0
Bladder cancer bladder B Bl Bla Blad BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 10 0 1 0 0 0
The bladder the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 . 1 10 0 1 0 0 0
urine samples urine u ur uri urin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 -. 2 10 0 1 0 0 0
Blood collection blood B Bl Blo Bloo BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 10 0 1 0 0 0
Blood from blood B Bl Blo Bloo BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 -- 2 10 0 1 0 0 0
tubes (Becton tubes t tu tub tube BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 (,). 4 10 0 0 0 0 0
started by started s st sta star BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 no 0 10 0 0 0 0 0
(without brake (without ( (w (wi (wit BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 (). 3 10 0 0 0 0 0
centrifuged again centrifuged c ce cen cent BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 (). 3 10 0 0 0 0 0
plasma was plasma p pl pla plas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 ,- 2 10 0 0 0 0 0
collection. Plasma collection. c co col coll BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 . 1 10 0 0 0 0 0
before RNA before b be bef befo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 . 1 10 0 0 0 0 0
For the for F Fo For For BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 10 ,. 2 10 0 0 0 0 0
DNA Tubes dna D DN DNA DNA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 10 (,).- 5 10 0 0 0 0 0
centrifugation at centrifugation c ce cen cent BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 11 ()- 3 10 0 0 0 0 0
hours of hours h ho hou hour BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 . 1 10 0 0 0 0 0
RNA isolation rna R RN RNA RNA BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 no 0 10 0 1 0 0 1
RNA was rna R RN RNA RNA BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 /(, 3 10 0 1 0 0 1
217184), according 217184), 2 21 217 2171 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 ),'.-- 6 10 0 0 0 0 1
cohort, 2 cohort, c co coh coho BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 ,-(/,,, 7 10 0 0 0 0 1
of Medical of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ,) 2 10 0 0 0 0 1
described 22 described d de des desc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .,- 3 10 0 0 0 0 1
sample lysates sample s sa sam samp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 2 (/() 4 10 0 0 0 0 1
µL of µl µ µL µL µL BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 2 ()-(, 5 10 0 0 0 0 1
4456740) were 4456740) 4 44 445 4456 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 ). 2 10 0 0 0 0 0
Genomic DNA genomic G Ge Gen Geno BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 3 -(,-). 6 10 0 0 0 0 0
reaction buffer reaction r re rea reac BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 (,),, 5 10 0 0 0 0 0
by 5 by b by by by BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 .- 2 10 0 0 0 0 0
library preparation. library l li lib libr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 . 1 10 0 0 0 0 0
Messenger RNA messenger M Me Mes Mess BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 5 ,, 2 10 0 0 0 0 0
MRNA capture mrna M MR MRN MRNA BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 --. 3 10 0 0 0 0 0
µL DNase µl µ µL µL µL BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 . 1 10 0 0 0 0 0
for Enrichment for f fo for for BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 (,).,, 6 10 0 0 0 0 0
and first and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 10 0 0 0 0 0
subsequently removed subsequently s su sub subs BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 10 0 0 0 0 0
XP beads xp X XP XP XP BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 (,)- 4 10 0 0 0 0 0
double stranded double d do dou doub BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 . 1 10 0 0 0 0 0
Prep with prep P Pr Pre Prep BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 8 (;,). 5 10 0 0 0 0 0
Tagmentation and tagmentation T Ta Tag Tagm BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 8 '. 2 10 0 0 0 0 0
Quality of quality Q Qu Qua Qual BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 8 - 1 10 0 0 0 0 0
Fragment Analysis fragment F Fr Fra Frag BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 9 (,--). 6 10 0 0 0 0 0
pooled per pooled p po poo pool BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 ,--,, 5 10 0 0 0 0 0
on their on o on on on BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 ,, 2 10 0 0 0 0 0
B2M, and b2m, B B2 B2M B2M, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 ,. 2 10 0 0 0 0 0
beads (Beckman beads b be bea bead BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 (,)., 5 10 0 0 0 0 0
probes from probes p pr pro prob BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 (,), 4 10 0 0 0 0 0
spike-in controls, spike-in s sp spi spik BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 -,(-). 6 10 0 0 0 0 0
the end the t th the the BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 10 0 1 0 0 1
quantification with quantification q qu qua quan BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (,). 4 10 0 1 0 0 1
Paired-end sequencing paired-end P Pa Pai Pair BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 -() 3 10 0 0 0 0 1
6000. For 6000. 6 60 600 6000 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 .-,(,) 6 10 0 0 0 0 1
standard workflow standard s st sta stan BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .().-, 6 10 0 0 0 0 1
kit (Illumina, kit k ki kit kit BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 1 (,).(). 7 10 0 0 0 0 1
Adapter trimming adapter A Ad Ada Adap BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 2 no 0 10 0 0 0 0 1
(v1.18). Read (v1.18). ( (v (v1 (v1. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 2 (.).(..)-: 10 10 0 0 0 0 1
only reads only o on onl only BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 () 2 10 0 0 0 0 0
were kept were w we wer were BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 (/).() 6 10 0 0 0 0 0
removed from removed r re rem remo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ., 2 10 0 0 0 0 0
plasma cohort plasma p pl pla plas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 (,,,) 5 10 0 0 0 0 0
samples in samples s sa sam samp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 5 -(,, 4 10 0 0 0 0 0
and 1 and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ). 2 10 0 0 0 0 0
mapped with mapped m ma map mapp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 (..)(--, 8 10 0 0 0 0 0
--outFilterMatchNmin 20 --outfiltermatchnmin - -- --o --ou BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ----). 6 10 0 0 0 0 0
analyses were analyses a an ana anal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 , 1 10 0 0 0 0 0
complemented with complemented c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 ., 2 10 0 0 0 0 0
(v0.11.0) in (v0.11.0) ( (v (v0 (v0. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 (..)-,. 7 10 0 0 0 0 0
Total RNA total T To Tot Tota BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 7 ,, 2 10 0 0 0 0 0
Total RNA total T To Tot Tota BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 7 no 0 10 0 0 0 0 0
RNA eluate rna R RN RNA RNA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 8 -- 2 10 0 0 0 0 0
(Takara, 634487) (takara, ( (T (Ta (Tak BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 8 (,)'. 5 10 0 0 0 0 0
prepared based prepared p pr pre prep BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 ( 1 10 0 0 0 0 0
Diagnostics, KK4854). diagnostics, D Di Dia Diag BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 9 ,).-() 6 10 0 0 0 0 0
NovaSeq 6000 novaseq N No Nov Nova BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 9 (,) 3 10 0 0 0 0 0
workflow loading workflow w wo wor work BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 10 .(). 4 10 0 0 0 0 0
After adapter after A Af Aft Afte BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 10 (.)(..), 8 10 0 0 0 0 0
reads were reads r re rea read BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 (..) 4 10 0 0 0 0 0
described above. described d de des desc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 .-(..) 6 10 0 0 0 0 0
the unique the t th the the BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 (). 3 10 0 0 0 0 0
counts were counts c co cou coun BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 0 (..), 5 10 0 0 0 0 1
uniquely mapping uniquely u un uni uniq BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 10 0 0 0 0 1
Data analyses data D Da Dat Data BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 10 0 1 0 0 0
Most data most M Mo Mos Most BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 (..)(..) 8 10 0 1 0 0 1
pheatmap (v1.0.12). pheatmap p ph phe phea BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 (..). 5 10 0 1 0 0 1
below. Color below. b be bel belo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 .'. 3 10 0 1 0 0 1
Detection threshold detection D De Det Dete BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 10 0 1 0 0 1
To remove to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 ,. 2 10 0 1 0 0 1
based on based b ba bas base BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 - 1 10 0 1 0 0 0
that have that t th tha that BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 -. 2 10 0 1 0 0 0
MRNA concentration mrna M MR MRN MRNA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 no 0 10 0 1 0 0 0
MRNA concentration mrna M MR MRN MRNA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 ., 2 10 0 0 0 0 0
Sequin spike-in sequin S Se Seq Sequ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 -- 2 10 0 0 0 0 0
in mix in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 4 . 1 10 0 0 0 0 0
multiplying the multiplying m mu mul mult BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 10 0 0 0 0 0
number of number n nu num numb BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 , 1 10 0 0 0 0 0
plasma volume plasma p pl pla plas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ., 2 10 0 0 0 0 0
considered and considered c co con cons BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ' 1 10 0 0 0 0 0
concentration. concentration. concentration. c co con conc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 10 0 0 0 0 0
Fusion gene fusion F Fu Fus Fusi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 10 0 0 0 0 0
FusionCatcher 27 fusioncatcher F Fu Fus Fusi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 7 (.). 4 10 0 0 0 0 0
Stringent filtering stringent S St Str Stri BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 : 1 10 0 0 0 0 0
FusionCatcher label fusioncatcher F Fu Fus Fusi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 7 , 1 10 0 0 0 0 0
mapping to mapping m ma map mapp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 , 1 10 0 1 0 0 0
were filtered were w we wer were BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 .- 2 10 0 1 0 0 0
compared to compared c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 (), 3 10 0 1 0 0 0
fusion genes fusion f fu fus fusi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 . 1 10 0 1 0 0 0
Differential abundance differential D Di Dif Diff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 10 0 1 0 0 0
DESeq2 (v1.36.0) deseq2 D DE DES DESe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 (..). 5 10 0 1 0 0 0
were pre-filtered were w we wer were BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 - 1 10 0 1 0 0 0
in at in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 10 ., 2 10 0 1 0 0 0
with a with w wi wit with BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 11 --(). 5 10 0 1 0 0 0
above 1 above a ab abo abov BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 10 0 0 0 0 1
performed with performed p pe per perf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 10 0 1 0 0 1
stabilizing transformation. stabilizing s st sta stab BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .(..) 5 10 0 1 0 0 1
and area-proportional and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 -(..). 6 10 0 1 0 0 1
abundance analysis abundance a ab abu abun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 (:./.). 7 10 0 1 0 0 1
Gene set gene G Ge Gen Gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 1 no 0 10 0 1 0 0 1
Fgsea 30 fgsea F Fg Fgs Fgse BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 (..) 4 10 0 1 0 0 1
transformed fold transformed t tr tra tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 10 0 1 0 0 1
abundance analysis. abundance a ab abu abun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 ... 3 10 0 1 0 0 0
Hallmark 9 hallmark H Ha Hal Hall BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 10 0 1 0 0 0
Genomes (KEGG) genomes G Ge Gen Geno BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 (),://.., 9 10 0 1 0 0 0
Database, MSigDB database, D Da Dat Data BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 ,(.)., 6 10 0 1 0 0 0
specific gene specific s sp spe spec BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 . 1 10 0 1 0 0 0
set enrichment set s se set set BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 10 0 1 0 0 0
(doi:10.5281/zenodo.7953707). Functional (doi:10.5281/zenodo.7953707). ( (d (do (doi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (:./.). 7 10 0 1 0 0 0
functional annotation functional f fu fun func BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 (),-- 5 10 0 1 0 0 0
of fgsea. of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ., 2 10 0 0 0 0 0
satisfying the satisfying s sa sat sati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 10 0 0 0 0 0
RNA Atlas rna R RN RNA RNA BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 7 no 0 10 0 0 0 0 0
These cell these T Th The Thes BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 no 0 10 0 0 0 0 0
lines in lines l li lin line BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 . 1 10 0 0 0 0 0
16 counts 16 1 16 16 16 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 8 no 0 10 0 0 0 0 0
10 compared 10 1 10 10 10 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 9 . 1 10 0 0 0 0 0
sets included sets s se set sets BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 . 1 10 0 0 0 0 0
Tabula Sapiens tabula T Ta Tab Tabu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 no 0 10 0 0 0 0 0
These cell these T Th The Thes BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 10 no 0 10 0 0 0 0 0
Vorperian et vorperian V Vo Vor Vorp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 10 . 1 10 0 0 0 0 0
at least at a at at at BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 11 . 1 10 0 0 0 0 0
out of out o ou out out BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 11 . 1 10 0 0 0 0 0
GTEX tissue gtex G GT GTE GTEX BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 10 0 1 0 0 1
These tissue these T Th The Thes BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 10 0 1 0 0 1
summarized in summarized s su sum summ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ://... 6 10 0 1 0 0 1
tissue gene tissue t ti tis tiss BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 .. 2 10 0 1 0 0 1
reduced to reduced r re red redu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 . 1 10 0 1 0 0 1
gene sets gene g ge gen gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 9 2 . 1 10 0 1 0 0 1
HPA-RNA Atlas hpa-rna H HP HPA HPA- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 - 1 10 0 1 0 0 1
These tissue these T Th The Thes BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 10 0 0 0 0 1
(HPA, v18, (hpa, ( (H (HP (HPA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 (,,://../)- 11 10 0 0 0 0 0
from the from f fr fro from BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 . 1 10 0 0 0 0 0
of at of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 10 0 0 0 0 0
compared to compared c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 . 1 10 0 0 0 0 0
finetuned by finetuned f fi fin fine BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 4 no 0 10 0 0 0 0 0
RNA Atlas rna R RN RNA RNA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ., 2 10 0 0 0 0 0
highest fold highest h hi hig high BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .. 2 10 0 0 0 0 0
TCGA cancer tcga T TC TCG TCGA BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 no 0 10 0 0 0 0 0
These gene these T Th The Thes BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 10 0 0 0 0 0
Cancer Genome cancer C Ca Can Canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 (), 3 10 0 0 0 0 0
Network: https://www.cancer.gov/tcga. network: N Ne Net Netw BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 :://../. 8 10 0 0 0 0 0
0.98 in 0.98 0 0. 0.9 0.98 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 ., 2 10 0 0 0 0 0
highest SPECS highest h hi hig high BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 .. 2 10 0 0 0 0 0
Cell type cell C Ce Cel Cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 8 no 0 10 0 0 0 0 0
NuSVR deconvolution nusvr N Nu NuS NuSV BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 8 no 0 10 0 0 0 0 0
by by by b by by by BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 no 0 2 0 1 0 0 0
Vorperian Vorperian vorperian V Vo Vor Vorp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 9 no 0 7 0 1 0 0 0
et et et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 9 no 0 2 0 1 0 0 0
al. 2 al. a al al. al. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 9 . 1 4 0 1 0 0 0
and and and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 no 0 3 0 1 0 0 0
the the the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 no 0 3 0 1 0 0 0
accompanying accompanying accompanying a ac acc acco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 no 0 10 0 1 0 0 0
GitHub GitHub github G Gi Git GitH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 9 no 0 5 0 1 0 0 0
repository, repository, repository, r re rep repo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 , 1 9 0 1 0 0 0
https://github.com/sevahn/deconvolution. As https://github.com/sevahn/deconvolution. h ht htt http BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 1 10 9 ://.//., 8 10 0 1 0 0 0
normalized and normalized n no nor norm BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 . 1 10 0 1 0 0 0
underestimated due underestimated u un und unde BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 . 1 10 0 1 0 0 0
Tail genes tail T Ta Tai Tail BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 no 0 10 0 1 0 0 0
To identify to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 , 1 10 0 1 0 0 0
z score z z z z z BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 10 11 , 1 10 0 1 0 0 0
samples except samples s sa sam samp BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 11 ., 2 10 0 1 0 0 0
normalized transcript normalized n no nor norm BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .,, 3 10 0 1 0 0 1
and standard and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 10 0 1 0 0 1
the transformed the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 . 1 10 0 0 0 0 1
Tail genes tail T Ta Tai Tail BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 1 no 0 10 0 0 0 0 1
deviating more deviating d de dev devi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 (). 3 10 0 0 0 0 1
For each for F Fo For For BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 1 : 1 10 0 0 0 0 1
𝑧𝑠𝑐𝑜𝑟𝑒 !"#" 𝑧𝑠𝑐𝑜𝑟𝑒 ? 𝑧 𝑧? 𝑧𝑠 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 !"#" 4 2 0 0 0 0 1
𝑙𝑜𝑔 $ 𝑙𝑜𝑔 ? 𝑙 𝑙? 𝑙𝑜 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 $*!"#"-!"#" 11 10 0 0 0 0 1
𝑆𝐷 %"& 𝑆𝐷 ? 𝑆 𝑆? 𝑆𝐷 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 "!"#" 5 1 0 0 0 0 1
where 𝑟𝑒𝑓 where w wh whe wher BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 no 0 1 0 0 0 0 0
88888 !"#" 88888 8 88 888 8888 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 2 !"#""!"#" 9 10 0 0 0 0 0
transformed counts transformed t tr tra tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 (). 3 10 0 0 0 0 0
Fisher's exact fisher's F Fi Fis Fish BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 3 '(/) 4 10 0 0 0 0 0
subset of subset s su sub subs BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ,, 2 10 0 0 0 0 0
disease state. disease d di dis dise BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 .,' 3 10 0 0 0 0 0
each tail each e ea eac each BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,, 2 10 0 0 0 0 0
needed to needed n ne nee need BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 (.). 4 10 0 0 0 0 0
result, the result, r re res resu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 ,. 2 10 0 0 0 0 0
Binary logistic binary B Bi Bin Bina BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ,, 2 10 0 0 0 0 0
as cancer as a as as as BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 .--- 4 10 0 0 0 0 0
validation was validation v va val vali BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 no 0 10 0 0 0 0 0
testing the testing t te tes test BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 7 ., 2 10 0 0 0 0 0
Characteristic (ROC) characteristic C Ch Cha Char BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 8 ()() 4 10 0 0 0 0 0
pROC (v1.18.0) proc p pR pRO pROC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 8 (..). 5 10 0 0 0 0 0
For internal for F Fo For For BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 8 , 1 10 0 0 0 0 0
in R in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 9 ., 2 10 0 0 0 0 0
on the on o on on on BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 (). 3 10 0 0 0 0 0
repeated 20 repeated r re rep repe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 . 1 10 0 0 0 0 0
Statistics Statistics statistics S St Sta Stat BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 no 0 10 0 0 0 0 0
Kruskal-Wallis tests kruskal-wallis K Kr Kru Krus BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 10 -,- 3 10 0 0 0 0 0
were used were w we wer were BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 . 1 10 0 0 0 0 0
calculated with calculated c ca cal calc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 11 (..).,-. 8 10 0 0 0 0 0
considered significant. considered c co con cons BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 11 .,- 3 10 0 0 0 0 0
used to used u us use used BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -(-) 4 10 0 0 0 0 1
defined as defined d de def defi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .. 2 10 0 0 0 0 1
Significance of significance S Si Sig Sign BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ' 1 10 0 0 0 0 1
GeneOverlap (v1.32.0). geneoverlap G Ge Gen Gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 1 (..). 5 10 0 0 0 0 1
differential abundance differential d di dif diff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 (). 3 10 0 0 0 0 1
calculated to calculated c ca cal calc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 , 1 10 0 0 0 0 1
100% indicating 100% 1 10 100 100% BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 2 . 1 10 0 0 0 0 1
Data availability data D Da Dat Data BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 3 no 0 10 0 0 0 0 0
Raw RNA-sequencing raw R Ra Raw Raw BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 3 -() 3 10 0 0 0 0 0
the European the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 -()' 4 10 0 0 0 0 0
with patient with w wi wit with BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 no 0 10 0 0 0 0 0
Regulation. The regulation. R Re Reg Regu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 .-- 3 10 0 0 0 0 0
EGAS00001006755 (dataset egas00001006755 E EG EGA EGAS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 (). 3 10 0 1 0 0 0
under study under u un und unde BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 (). 3 10 0 1 0 0 0
FASTQs can fastqs F FA FAS FAST BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 (). 3 10 0 1 0 0 0
Differential abundance differential D Di Dif Diff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 () 2 10 0 1 0 0 0
in a in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 7 (:./.). 7 10 0 1 0 0 0
Code availability code C Co Cod Code BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 7 no 0 10 0 1 0 0 0
Code for code C Co Cod Code BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 7 no 0 10 0 1 0 0 0
https://github.com/OncoRNALab/tailgenes. https://github.com/OncoRNALab/tailgenes. https://github.com/oncornalab/tailgenes. h ht htt http BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 1 10 7 ://.//. 7 10 0 1 0 0 0
Acknowledgements Acknowledgements acknowledgements A Ac Ack Ackn BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 8 no 0 10 0 1 0 0 0
Figures 1a figures F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 8 .. 2 10 0 1 0 0 0
providing the providing p pr pro prov BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 , 1 10 0 1 0 0 0
the first the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 ,. 2 10 0 1 0 0 0
Funding Funding funding F Fu Fun Fund BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 no 0 10 0 1 0 0 0
This work this T Th Thi This BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 (;//), 6 10 0 1 0 0 0
Hospital, Fund hospital, H Ho Hos Hosp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 ,(;..,.., 9 10 0 0 0 0 0
G0B2820N), and g0b2820n), G G0 G0B G0B2 BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 11 ),(,). 6 10 0 0 0 0 0
Conflict of conflict C Co Con Conf BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 10 0 1 0 0 1
A.M., J.V. a.m., A A. A.M A.M. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..,..... 8 10 0 0 0 0 1
References References references R Re Ref Refe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 10 0 0 0 0 0
1. Pessoa, 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 .,..,,.,..:. 12 10 0 0 0 0 1
Critical Reviews critical C Cr Cri Crit BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 1 /,(). 5 10 0 0 0 0 1
2. Vorperian, 2. 2 2. 2. 2. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 2 .,..,,..,..- 12 10 0 0 0 0 1
transcriptome. Nat transcriptome. t tr tra tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 3 .,-(). 6 10 0 0 0 0 0
3. Moufarrej, 3. 3 3. 3. 3. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 3 .,...-. 7 10 0 0 0 0 0
Nature 602, nature N Na Nat Natu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 ,-(). 5 10 0 0 0 0 0
4. Larson, 4. 4 4. 4. 4. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,...- 6 10 0 0 0 0 0
reveals tissue-and reveals r re rev reve BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 --., 4 10 0 0 0 0 0
2357 (2021). 2357 2 23 235 2357 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 11 5 (). 3 10 0 0 0 0 0
5. Chen, 5. 5 5. 5. 5. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,..- 5 10 0 0 0 0 0
and microbes. and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .,(). 5 10 0 0 0 0 0
6. Roskams-Hieter, 6. 6 6. 6. 6. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 .-,..-- 7 10 0 0 0 0 0
malignant conditions malignant m ma mal mali BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 7 ...,- 5 10 0 0 0 0 0
(2022). (2022). (2022). ( (2 (20 (202 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 8 (). 3 10 0 0 0 0 0
7. Bryzgunova, 7. 7 7. 7. 7. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,..,,..,..- 12 10 0 0 0 0 0
different tumor different d di dif diff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 .,-(). 6 10 0 0 0 0 0
8. Liquori, 8. 8 8. 8. 8. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 9 .,..: 5 10 0 0 0 0 0
around a around a ar aro arou BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 -.(),(). 8 10 0 0 0 0 0
9. Liberzon, 9. 9 9. 9. 9. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 10 .,..() 6 10 0 0 0 0 0
collection. Cell collection. c co col coll BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 11 .,-(). 6 10 0 0 0 0 0
10. Kanehisa, 10. 1 10 10. 10. BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.,.:. 7 10 0 1 0 0 1
Research 28, research R Re Res Rese BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 0 ,-(). 5 10 0 0 0 0 1
11. Khwaja, 11. 1 11 11. 11. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,...,-(). 10 10 0 0 0 0 1
12. Giannakeas, 12. 1 12 12. 12. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 1 .,..- 5 10 0 0 0 0 1
Period. JAMA period. P Pe Per Peri BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 2 .,(). 5 10 0 0 0 0 1
13. Haemmerle, 13. 1 13 13. 13. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 2 .,.,,..,,..,-,.,.. 18 10 0 0 0 0 1
Lifeline to lifeline L Li Lif Life BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 3 :.,-(). 7 10 0 0 0 0 0
14. Hulstaert, 14. 1 14 14. 14. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 .,... 5 10 0 0 0 0 0
Cell Reports cell C Ce Cel Cell BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 4 ,(). 4 10 0 0 0 0 0
15. Sun, 15. 1 15 15. 15. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 .,..- 5 10 0 0 0 0 0
noninvasive prenatal, noninvasive n no non noni BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 ,,. 3 10 0 0 0 0 0
National Academy national N Na Nat Nati BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 5 ,-(). 5 10 0 0 0 0 0
16. Hulstaert, 16. 1 16 16. 16. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,..- 5 10 0 0 0 0 0
invasive invasive invasive i in inv inva BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 no 0 4 0 0 0 0 0
prostate prostate prostate p pr pro pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 no 0 4 0 0 0 0 0
cancer cancer cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 3 0 0 0 0 0
diagnosis. diagnosis. diagnosis. d di dia diag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 5 0 0 0 0 0
2021.05.11.21256306 2021.05.11.21256306 2021.05.11.21256306 2 20 202 2021 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ... 3 10 0 0 0 0 0
Preprint Preprint preprint P Pr Pre Prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 no 0 4 0 0 0 0 0
at at at a at at at BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 1 0 0 0 0 0
https://doi.org/10.1101/2021.05.11.21256306 (2021). https://doi.org/10.1101/2021.05.11.21256306 h ht htt http BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 11 7 ://././...(). 13 10 0 0 0 0 0
17. Allen, 17. 1 17 17. 17. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 .,... 5 10 0 0 0 0 0
in cancer in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 8 .,-(). 6 10 0 0 0 0 0
18. Hiam-Galvez, 18. 1 18 18. 18. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .-,..,,..,... 13 10 0 0 0 0 0
Cancer 21, cancer C Ca Can Canc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 9 ,-(). 5 10 0 0 0 0 0
19. Xiong, 19. 1 19 19. 19. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 9 .,.,,.,.. 9 10 0 0 0 0 0
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 ,(). 4 10 0 0 0 0 0
20. Lugano, 20. 2 20 20. 20. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 10 .,.,,.,.:,, 11 10 0 0 0 0 0
challenges and challenges c ch cha chal BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 11 ....,-(). 9 10 0 0 0 0 0
21. Consortium, 21. 2 21 21. 21. BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,. 3 10 0 1 0 0 1
tubes in tubes t tu tub tube BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ().... 6 10 0 0 0 0 1
Preprint at preprint P Pr Pre Prep BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ://././...(). 13 10 0 0 0 0 1
22. Hulstaert, 22. 2 22 22. 22. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 1 .,.. 4 10 0 0 0 0 1
biofluids using biofluids b bi bio biof BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 1 -.,(). 6 10 0 0 0 0 1
23. Dobin, 23. 2 23 23. 23. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 2 .,..:-.,-(). 12 10 0 0 0 0 1
24. Anders, 24. 2 24 24. 24. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 3 .,.,,..,.-- 11 10 0 0 0 0 0
throughput sequencing throughput t th thr thro BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 3 .,-(). 6 10 0 0 0 0 0
25. Tol, 25. 2 25 25. 25. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 .,.,///-.(). 12 10 0 0 0 0 0
26. Mestdagh, 26. 2 26 26. 26. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 .,.. 4 10 0 0 0 0 0
microRNA quality microrna m mi mic micr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 ().,-(). 8 10 0 0 0 0 0
27. Nicorici, 27. 2 27 27. 27. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,..-- 6 10 0 0 0 0 0
RNA-sequencing data. rna-sequencing R RN RNA RNA- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 -.://././(). 12 10 0 0 0 0 0
28. Kim, 28. 2 28 28. 28. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,.,.:. 7 10 0 0 0 0 0
47, D994-D1004 47, 4 47 47, 47, BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 ,-(). 5 10 0 0 0 0 0
29. Gao, 29. 2 29 29. 29. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 .,.. 4 10 0 0 0 0 0
Human Cancers. human H Hu Hum Huma BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 .,-.(). 7 10 0 0 0 0 0
30. Korotkevich, 30. 3 30 30. 30. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,... 5 10 0 0 0 0 0
https://doi.org/10.1101/060012 (2021). https://doi.org/10.1101/060012 h ht htt http BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 11 9 ://././(). 10 10 0 0 0 0 0
31. Subramanian, 31. 3 31 31. 31. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 9 .,..:- 6 10 0 0 0 0 0
interpreting genome-wide interpreting i in int inte BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 -. 2 10 0 0 0 0 0
Sciences 102, sciences S Sc Sci Scie BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 ,-(). 5 10 0 0 0 0 0
32. Huang, 32. 3 32 32. 32. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 10 .,..,,..,.. 11 10 0 0 0 0 0
gene lists gene g ge gen gene BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 11 11 .,-(). 6 10 0 0 0 0 0
33. Sherman, 33. 3 33 33. 33. BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,...: 6 10 0 1 0 0 1
functional annotation functional f fu fun func BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 1 ().,- 5 10 0 0 0 0 1
(2022). (2022). (2022). ( (2 (20 (202 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 2 (). 3 10 0 0 0 0 0
34. Lorenzi, 34. 3 34 34. 34. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 2 .,..-. 6 10 0 0 0 0 1
Biotechnol 39, biotechnol B Bi Bio Biot BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 ,-(). 5 10 0 0 0 0 1
35. Everaert, 35. 3 35 35. 35. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 .,.,,.-.,,.,,.,.:- 18 10 0 0 0 0 1
method to method m me met meth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 -. 2 10 0 0 0 0 0
Bioinformatics 21, bioinformatics B Bi Bio Bioi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,(). 4 10 0 0 0 0 0
36. Lonsdale, 36. 3 36 36. 36. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 .,..-().,- 10 10 0 0 0 0 0
(2013). (2013). (2013). ( (2 (20 (201 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 8 (). 3 10 0 0 0 0 0
37. Uhlén, 37. 3 37 37. 37. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,..-.,(). 10 10 0 0 0 0 0
38. Robin, 38. 3 38 38. 38. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 9 .,..:- 6 10 0 0 0 0 0
curves. BMC curves. c cu cur curv BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 11 .,(). 5 10 0 0 0 0 0

